Berberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells
- PMID: 19052522
- PMCID: PMC6244848
- DOI: 10.3390/molecules13122975
Berberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells
Abstract
Invasion of cancer cell induced by matrix metalloproteinase-9 (MMP-9) is one of pivotal steps in cancer metastasis. Herein, we investigated how cell invasion was regulated by berberine (BBR), an isoquinoline derivative alkaloid compound, in MDA-MB-231 human breast cancer cells. The basal level of MMP-9 activity and expression was dose-dependently increased by TNF-alpha, while TNF-a-induced MMP-9 gelatinase activity and expression was decreased by BBR. To investigate regulatory mechanism of TNF-alpha-induced MMP-9 expression, we pretreated cells with UO126 (MEK inhibitor), SB203580 (p38 inhibitor) and SP600125 (JNK inhibitor), respectively. Interestingly, TNF-alpha-induced MMP-9 activity and expression was decreased by UO126 and SB203580, but not by SP600125. Therefore, we further examined the effects of BBR on TNF-alpha-induced AP-1 DNA binding activity which is a downstream _target of ERK and p38. Our data showed that TNF-alpha-induced AP-1 DNA binding activity was inhibited by BBR. Finally, we investigated the effect of BBR on TNF-alpha-induced cell invasion. TNF-alpha-induced cell invasion was significantly decreased by BBR treatment. Taken together, we suggest that TNF-alpha-induced MMP-9 expression and cell invasion are decreased by BBR through the suppression of AP-1 DNA binding activity in MDA-MB-231 human breast cancer cells.
Figures
Similar articles
-
Berberine suppresses the TPA-induced MMP-1 and MMP-9 expressions through the inhibition of PKC-α in breast cancer cells.J Surg Res. 2012 Jul;176(1):e21-9. doi: 10.1016/j.jss.2011.11.1041. Epub 2011 Dec 30. J Surg Res. 2012. PMID: 22381172
-
Inhibition of cell invasion and migration by _targeting matrix metalloproteinase-9 expression via sirtuin 6 silencing in human breast cancer cells.Sci Rep. 2022 Jul 15;12(1):12125. doi: 10.1038/s41598-022-16405-x. Sci Rep. 2022. PMID: 35840633 Free PMC article.
-
Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells.Phytomedicine. 2009 Jun;16(6-7):573-80. doi: 10.1016/j.phymed.2008.11.006. Epub 2009 Jan 31. Phytomedicine. 2009. PMID: 19181503
-
Effect of berberine on p53 expression by TPA in breast cancer cells.Oncol Rep. 2012 Jan;27(1):210-5. doi: 10.3892/or.2011.1480. Epub 2011 Sep 29. Oncol Rep. 2012. PMID: 21964832
-
Current understanding and future prospects on Berberine for anticancer therapy.Chem Biol Drug Des. 2023 Jul;102(1):177-200. doi: 10.1111/cbdd.14231. Epub 2023 Apr 1. Chem Biol Drug Des. 2023. PMID: 36905314 Review.
Cited by
-
ACSL1 Regulates TNFα-Induced GM-CSF Production by Breast Cancer MDA-MB-231 Cells.Biomolecules. 2019 Oct 1;9(10):555. doi: 10.3390/biom9100555. Biomolecules. 2019. PMID: 31581558 Free PMC article.
-
Berberine Attenuates Cell Motility via Inhibiting Inflammation-Mediated Lysyl Hydroxylase-2 and Glycolysis.Front Pharmacol. 2022 Apr 26;13:856777. doi: 10.3389/fphar.2022.856777. eCollection 2022. Front Pharmacol. 2022. PMID: 35559258 Free PMC article.
-
Synthesis and cytotoxicity evaluation of 13-n-alkyl berberine and palmatine analogues as anticancer agents.Molecules. 2012 Sep 25;17(10):11294-302. doi: 10.3390/molecules171011294. Molecules. 2012. PMID: 23011273 Free PMC article.
-
The Effects of Adipocytes on the Regulation of Breast Cancer in the Tumor Microenvironment: An Update.Cells. 2019 Aug 8;8(8):857. doi: 10.3390/cells8080857. Cells. 2019. PMID: 31398937 Free PMC article. Review.
-
Silibinin suppresses TNF-alpha-induced MMP-9 expression in gastric cancer cells through inhibition of the MAPK pathway.Molecules. 2009 Oct 26;14(11):4300-11. doi: 10.3390/molecules14114300. Molecules. 2009. PMID: 19924065 Free PMC article.
References
-
- Oka T., Ishida T., Nishino T., Sugimachi K. Immunohistochemical evidence of urokinase-type plasminogen activator in primary and metastatic tumors of pulmonary adenocarcinoma. Cancer Res. 1991;51:3522–3525. - PubMed
-
- Deryugina E.I., Quigley J.P. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006;25:9–34. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous